|
|
|
Volumn 21, Issue 1, 2002, Pages 87-93
|
|
Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent
a
a
a
a
|
|
Author keywords
EAC; Human tumour lines; New anticancer agent; S 180
|
|
Indexed keywords
2 [2 [3 (2 CHLOROETHYL) 3 NITROSOUREIDO]ETHYL] 1H BENZ[DE]ISOQUINOLINE 1,3 DIONE;
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
LOMUSTINE;
NAPHTHALIMIDE DERIVATIVE;
NITROSOUREA DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
ASCITES TUMOR;
BONE MARROW CELL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SCREENING;
DRUG SYNTHESIS;
EHRLICH ASCITES TUMOR;
HEMATOPOIESIS;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
LIVER TOXICITY;
MALE;
MOUSE;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
SARCOMA;
SPLEEN CELL;
SURVIVAL TIME;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CARCINOMA, EHRLICH TUMOR;
DRUG EVALUATION, PRECLINICAL;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
KIDNEY;
LIVER;
LOMUSTINE;
MALE;
MICE;
SARCOMA 180;
TUMOR CELLS, CULTURED;
|
|
EID: 0036223432
PISSN: 03929078
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (13)
|
